Cancer / Oncology
Paige Partners with Microsoft to Create World's Largest Cancer-Fighting AI Model
Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images ...
September 08, 2023 | News
"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"
In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC delve into the recently i...
September 06, 2023 | News
HiRO Boosts G lobal Presence and Operations with Courante Oncology Acquisition
As a reputable boutique CRO with a strong track record of delivering high-quality, expedited clinical trials in the Asia-Pacific, HiRO's acquisit...
September 01, 2023 | News
Zhiyi Biotech Begins Phase 1 Trial of SK10 for Chemo-induced Diarrhea
SK10, the first Bacteroides fragilis-based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probi...
August 28, 2023 | News
Akeso's Ebdarokimab NDA Accepted by China NMPA for Psoriasis
Ebdarokimab is Akeso's 6th self-developed innovative drug that has been successfully approved for marketing/NDA submitted, the first patented domestic inno...
August 25, 2023 | News
First Patient Dosed in TLX101 Brain Cancer Study for Newly Diagnosed Glioblastoma
IPAX-2 (ClinicalTrials.gov Identifier: NCT05450744) is a Phase I dose escalation study to confirm safety profile of TLX101 in combination with externa...
August 08, 2023 | News
HaemaLogiX, Peter MacCallum Cancer Centre Announce Myeloma CAR-T Trial Agreement
HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's ...
July 26, 2023 | News
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
SABRE (Copper-64 SAR-Bombesin in Biochemical Recurrence of prostate cancer) is a Phase II Positron Emission Tomography (PET) imaging tr...
July 25, 2023 | News
RenovoRx and Imugene Join Forces for Oncolytic Virus Therapy Using TAMP Platform
Collaboration will explore trans-arterial delivery of Imugene's CF33 oncolytic virus utilizing RenovoRx's TAMP therapy platform TAMP enables localized, ...
July 25, 2023 | News
Menarini Silicon Biosystems Launches New CELLSEARCH® CTC Test for Small Cell Lung Cancer with DLL3 Biomarker
Menarini Silicon Biosystems (MSB), a pioneer in liquid biopsy and single cell technologies, announced today the availability of its new CELLSEARCH CTC...
July 14, 2023 | News
NK:IO Secures £1.6M Innovate UK Grant for Pioneering Cancer Therapy
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pionee...
July 11, 2023 | News
GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs
Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...
July 07, 2023 | News
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China
The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single agent for the second line treatment ...
July 05, 2023 | News
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology
By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...
June 29, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
